Directory
Rosa Maria Marti Laborda

Rosa Maria Marti Laborda

Degree: PhD

973 70 52 38
marti(ELIMINAR)@medicina.udl.cat

ResearcherID: http://www.researcherid.com/rid/A-2256-2010

Publications

  • Matas-Nadal, C; Malvehy, J; Ferreres, JR; Boada, A; Bodet, D; Segura, S; Salleras, M; Azon, A; Bel-Pla, S; Bigata, X; Campoy, A; Curco, N; Dalmau, J; Formigon, M; Gonzalez, A; Just, M; Llistosella, E; Nogues, ME; Pedragosa, R; Pujol, JA; Sabat, M; Smandia, JA; Zaballos, P; Puig, S; Marti, RM

    Increasing incidence of lentigo maligna and lentigo maligna melanoma in Catalonia

    International journal of dermatology 58 577-581. .

    [doi:10.1111/ijd.14334]

  • Georgouli, M; Herraiz, C; Crosas-Molist, E; Fanshawe, B; Maiques, O; Perdrix, A; Pandya, P; Rodriguez-Hernandez, I; Ilieva, KM; Cantelli, G; Karagiannis, P; Mele, S; Lam, H; Josephs, DH; Matias-Guiu, X; Marti, RM; Nestle, FO; Orgaz, JL; Malanchi, I; Fruhwirth, GO; Karagiannis, SN; Sanz-Moreno, V

    Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment

    Cell 176 757-77423. .

    [doi:10.1016/j.cell.2018.12.038]

  • Lopez-Lerma, I; Peñate Y; Gallardo, F; Marti, RM; Mitxelena, J; Bielsa, I; Velasco-Tamariz, V; Yanguas-Bayona, JI; Sanchez-Sambucety, P; Garcia-Patos, V; Ortiz-Romero, PL; Pujol, RM; Estrach, T

    Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patients

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 79 892-898. .

    [doi:10.1016/j.jaad.2018.05.1243]

  • Fernandez-de-Misa, Ricardo; Hernandez-Machin, Buenaventura; Combalia, Andrea; Garcia-Muret, MD; Servitje, Octavio; Muniesa, Cristina; Gallardo, Fernando; Rujol, RM; Marti, RM; Ortiz-Brugues, Ariadna; Maronas-Jimenez, Lidia; Ortiz-Romero, PL; Blanch-Rius, Laura; Roman, Concepcion; Canueto, Javier; Mar, Blanes; Bastida, Jesus; Morillo, Mercedes; Penate, Yeray; Gala, SP; Molins, Marta; Lara, PE; Gil, AP; Estrach, Teresa

    Primary cutaneous anaplastic large cell lymphoma (pcALCL): Initial approach and long-term follow-up in 108 patients.

    EUROPEAN JOURNAL OF CANCER 101 19-20. .

    [doi:10.1016/j.ejca.2018.07.257]

  • Fernandez Armenteros, Jose Manuel; Arco Huguet, Nuria; Sanmartin Novell, Veronica; Vilardell Villellas, Felip; Velasco Sanchez, Ana; Martro Catala, Elisa; Marti Laborda, Rosa Maria; Soria Gili, Xavier

    Langerhans cell histiocytosis mimicking molluscum contagiosum: A case series

    PEDIATRIC BLOOD & CANCER 65 -. .

    [doi:10.1002/pbc.27047]

  • Maiques, O; Barcelo, C; Panosa, A; Pijuan, J; Orgaz, JL; Rodriguez-Hernandez, I; Matas-Nadal, C; Tell, G; Vilella, R; Fabra, A; S P; Sanz-Moreno, V; Matias-Guiu, X; Canti, C; Herreros, J; Marti, RM; Macia, A

    T-type calcium channels drive migration/invasion in BRAFV600E melanoma cells through Snail1

    PIGMENT CELL & MELANOMA RESEARCH 31 484-495. .

    [doi:10.1111/pcmr.12690]

  • Matas-Nadal, C; Sòria X; Garcia-de-la-Fuente, MR; Huerva, V; Ortega, E; Vilardell, F; Gatius, S; Casanova, JM; Marti, RM

    Immunocryosurgery as monotherapy for lentigo maligna or combined with surgical excision for lentigo maligna melanoma

    JOURNAL OF DERMATOLOGY 45 564-570. .

    [doi:10.1111/1346-8138.14248]

  • Fernandez Armenteros JM; Veà Jódar A; Matas Nadal C; Cortés Pinto C; Soria Gili X; Martí Laborda RM; Vilardell Villellas F; Casanova Seuma JM

    Severe and recurrent levamisole-induced cutaneous vasculopathy

    JOURNAL OF CUTANEOUS PATHOLOGY 45 309-311. .

    [doi:10.1111/cup.13105]

  • Fernández-de-Misa R; Hernández-Machín B; Servitje O; Valentí-Medina F; Maroñas-Jiménez L; Ortiz-Romero PL; Sánchez Schmidt J; Pujol RM; Gallardo F; Pau-Charles I; García Muret MP; Pérez Gala S; Román C; Cañueto J; Blanch Rius L; Izu R; Ortiz-Brugués A; Martí RM; Blanes M; Morillo M; Sánchez P; Peñate Y; Bastida J; Pérez Gil A; Lopez-Lerma I; Muniesa C; Estrach T

    First-line treatment in lymphomatoid papulosis: a retrospective multicentre study

    CLINICAL AND EXPERIMENTAL DERMATOLOGY 43 137-143. .

    [doi:10.1111/ced.13256]

  • Rozas-Munoz, E; Gallardo, F; Pujol, RM; Perez-Ferriols, A; Servitje, O; Estrach, T; Bastida, J; Roman, C; Palacio-Aller, L; Gil, I; Marti, RM; Vidal-Sarro, D; Garcia-Muret, MP

    Extranodal natural killer/T-cell lymphoma, nasal type: a Spanish multicentric retrospective survey

    EUROPEAN JOURNAL OF DERMATOLOGY 28 64-70. .

    [doi:10.1684/ejd.2017.3205]

  • Barcelo, C; Maiques, O; Panosa, A; Pijuan, J; Orgaz, JL; Vilella, R; Fabra, A; Puig, S; Sanz-Moreno, V; Matias-Guiu, X; Herreros, J; Canti, C; Macia, A; Marti, RM

    T-type calcium channel blockers reduce migration/invasion in BRAFV600E melanoma cells by inhibiting autophagy

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 31 66-66. .

  • Maiques, O; Moreno, S; Romero, M; Santacana, M; Gomez, I; Velasco, A; Macia, A; Barcelo, C; Boix, R; Valls, J; Gatius, S; Canti, C; Matias-Guiu, X; Soria, X; Marti, RM

    Differential immunoexpression of senescence markers, tumor suppressor genes, BRAF-V600E and T-type calcium channels in acquired nevi according to their histopathological and dermoscopic classification

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 31 65-65. .

Projects

  • OncoNeoVac, un nuevo enfoque inmunoterapéutico para el tratamiento del melanoma.
  • Análisis del microambiente tumoral del melanoma cutáneo asociado al perfil genético y/o a la aparición de resistencias
  • Estudio genético y análisis del secretoma del Melanoma Acral. Identificación de biomarcadores de aplicación clínica
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • Análisis del secretoma en el melanoma humano asociado al perfil genético y a la aparición de resistencias. Identificación de biomarcadores y/o dianas terapéuticas de aplicación clínica
  • POSTDOCTORAL AECC 2017: ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA HUMANO. ESTUDIO DE LAS RESISTENCIAS A FARMACOS CONVENCIONALES Y EL PROCESO AUTOFAGICO
  • ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA
  • IMPLEMENTATION OF PERSONALIZE MEDICINE IN CUTANEOUS MELANOMA BASED ON GENOMIC SUSCEPTIBILITY AND TUMOR SIGNATURES: IDENTIFICATION OF NEW TARGETS FOR MELANOMA TREATMENT
  • EXPRESION DE CANALES DE CALCIO DE TIPO T EN NEOPLASIAS MELANOCÍTICAS BENIGNAS Y MALIGNAS. EVALUACION DE SU APLICICABILIDAD CLINICA COMO DIANAS TERAPEUTICAS EN EL MELANOMA
  • UNA FLOR PER A UN PROJECTE: ESTUDI DE DOS FARMACS PEL TRACTAMENT DEL MELANOMA
  • GOTTA - ALTERACIONS MOLECULARS DEL MELANOMA
  • Efecto de los inhib idores del proteasoma en células de melanoma